Impact of CYP2D6 Genotype on Amitriptyline Efficacy for the Treatment of Diabetic Peripheral Neuropathy: A Pilot Study
Open Access
- 28 March 2017
- journal article
- research article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 18 (5) , 433-443
Abstract
Aim: Therapy with low-dose amitriptyline is commonly used to treat painful diabetic peripheral neuropathy. There is a knowledge gap, however, regarding the role of variable CYP2D6-mediated drug metabolism and side effects (SEs). We aimed to generate pilot data to demonstrate that SEs are more frequent in patients with variant CYP2D6 alleles. Method: To that end, 31 randomly recruited participants were treated with low-dose amitriptyline for painful diabetic peripheral neuropathy and their CYP2D6 gene sequenced. Results: Patients with predicted normal or ultra-rapid metabolizer phenotypes presented with less SEs compared with individuals with decreased CYP2D6 activity. Conclusion: Hence, CYP2D6 genotype contributes to treatment outcome and may be useful for guiding drug therapy. Future investigations in a larger patient population are planned to support these preliminary findings.Keywords
Funding Information
- South African Medical Research Council
- National Research Foundation of South Africa
- National Health Laboratory Services
- Institute for Cellular and Molecular Medicine
- University of Pretoria
This publication has 27 references indexed in Scilit:
- Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort studyBMC Medical Genetics, 2013
- Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic AntidepressantsClinical Pharmacology & Therapeutics, 2013
- Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathyIndian Journal of Pharmacology, 2012
- Elucidation of CYP2D6 Genetic Diversity in a Unique African Population: Implications for the Future Application of Pharmacogenetics in the Xhosa PopulationAnnals of Human Genetics, 2010
- Polymorphism of human cytochrome P450 enzymes and its clinical impactDrug Metabolism Reviews, 2009
- Burden of Illness in Painful Diabetic Peripheral Neuropathy: The Patients’ PerspectivesThe Journal of Pain, 2006
- EFNS guidelines on pharmacological treatment of neuropathic painEuropean Journal of Neurology, 2006
- Amitriptyline or Not, That Is the Question: Pharmacogenetic Testing of CYP2D6 and CYP2C19 Identifies Patients with Low or High Risk for Side Effects in Amitriptyline TherapyClinical Chemistry, 2005
- Management of Diabetic Peripheral NeuropathyClinical Diabetes, 2005
- Estimation of the Means of Dependent VariablesThe Annals of Mathematical Statistics, 1958